Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Mar;63(3):280–284. doi: 10.1136/ard.2003.008680

Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis

A Barton 1, H Platt 1, F Salway 1, D Symmons 1, E Barrett 1, M Bukhari 1, M Lunt 1, E Zeggini 1, S Eyre 1, A Hinks 1, D Tellam 1, B Brintnell 1, W Ollier 1, J Worthington 1, A Silman 1
PMCID: PMC1754913  PMID: 14962963

Abstract

Background: Tumour necrosis factor alpha (TNFα) is a powerful inflammatory mediator in rheumatoid and other types of inflammatory arthritis. Polymorphisms within the TNFα gene have previously been investigated to determine their role in the aetiopathogenesis of rheumatoid arthritis (RA), but it is unclear whether reported associations are with susceptibility to, or severity of, disease.

Objective: To examine the association between both individual TNFα single nucleotide polymorphisms (SNPs) and haplotypes with the development and severity of erosions by 5 years in patients with inflammatory polyarthritis (IP).

Methods: 438 patients from the Norfolk Arthritis Register observational inception cohort of patients with IP were x rayed 5 years after disease onset. They were genotyped for nine SNPs mapping to the TNFα gene, using a SNaPshot primer extension assay. Haplotypes were constructed in patients with IP, who were compared for the presence and extent of erosions at 5 years.

Results: No association between individual TNFα SNPs or haplotypes in the patients who developed erosions at 5 years compared with those who remained non-erosive was found. Restricting analysis to patients who satisfied ACR criteria for RA by 5 years did not affect the conclusions.

Conclusion: The TNFα gene does not seem to be associated with severity as assessed by erosive outcome at 5 years in patients with IP.

Full Text

The Full Text of this article is available as a PDF (244.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Bondeson J., Maini R. N. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE). Int J Clin Pract. 2001 Apr;55(3):211–216. [PubMed] [Google Scholar]
  3. Braun N., Michel U., Ernst B. P., Metzner R., Bitsch A., Weber F., Rieckmann P. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett. 1996 Sep 6;215(2):75–78. [PubMed] [Google Scholar]
  4. Brinkman B. M., Huizinga T. W., Breedveld F. C., Verweij C. L. Allele-specific quantification of TNFA transcripts in rheumatoid arthritis. Hum Genet. 1996 Jun;97(6):813–818. doi: 10.1007/BF02346195. [DOI] [PubMed] [Google Scholar]
  5. Brinkman B. M., Huizinga T. W., Kurban S. S., van der Velde E. A., Schreuder G. M., Hazes J. M., Breedveld F. C., Verweij C. L. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol. 1997 May;36(5):516–521. doi: 10.1093/rheumatology/36.5.516. [DOI] [PubMed] [Google Scholar]
  6. Bukhari M. A. S., Wiles N. J., Lunt M., Harrison B. J., Scott D. G. I., Symmons D. P. M., Silman A. J. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum. 2003 Jan;48(1):46–53. doi: 10.1002/art.10727. [DOI] [PubMed] [Google Scholar]
  7. Bukhari M., Harrison B., Lunt M., Scott D. G., Symmons D. P., Silman A. J. Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum. 2001 Jun;44(6):1248–1253. doi: 10.1002/1529-0131(200106)44:6<1248::AID-ART215>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  8. Cvetkovic Jasmina Trifunovic, Wallberg-Jonsson Solveig, Stegmayr Birgitta, Rantapaa-Dahlqvist Solbritt, Lefvert Ann Kari. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. J Rheumatol. 2002 Feb;29(2):212–219. [PubMed] [Google Scholar]
  9. Deighton C. M., Walker D. J., Griffiths I. D., Roberts D. F. The contribution of HLA to rheumatoid arthritis. Clin Genet. 1989 Sep;36(3):178–182. doi: 10.1111/j.1399-0004.1989.tb03185.x. [DOI] [PubMed] [Google Scholar]
  10. Dugowson C. E., Nelson J. L., Koepsell T. D. Evaluation of the 1987 revised criteria for rheumatoid arthritis in a cohort of newly diagnosed female patients. Arthritis Rheum. 1990 Jul;33(7):1042–1046. doi: 10.1002/art.1780330718. [DOI] [PubMed] [Google Scholar]
  11. Fabris Martina, Di Poi Emma, D'Elia Angela, Damante Giuseppe, Sinigaglia Luigi, Ferraccioli Gianfranco. Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis. J Rheumatol. 2002 Jan;29(1):29–33. [PubMed] [Google Scholar]
  12. Feldmann M., Brennan F. M., Maini R. N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. [DOI] [PubMed] [Google Scholar]
  13. Field M., Gallagher G., Eskdale J., McGarry F., Richards S. D., Munro R., Oh H. H., Campbell C. Tumor necrosis factor locus polymorphisms in rheumatoid arthritis. Tissue Antigens. 1997 Sep;50(3):303–307. doi: 10.1111/j.1399-0039.1997.tb02874.x. [DOI] [PubMed] [Google Scholar]
  14. Jawaheer Damini, Li Wentian, Graham Robert R., Chen Wei, Damle Aarti, Xiao Xiangli, Monteiro Joanita, Khalili Houman, Lee Annette, Lundsten Robert. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet. 2002 Aug 9;71(3):585–594. doi: 10.1086/342407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kaijzel E. L., Bayley J. P., van Krugten M. V., Smith L., van de Linde P., Bakker A. M., Breedveld F. C., Huizinga T. W., Verweij C. L. Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes Immun. 2001 May;2(3):135–144. doi: 10.1038/sj.gene.6363747. [DOI] [PubMed] [Google Scholar]
  16. Kaijzel E. L., van Krugten M. V., Brinkman B. M., Huizinga T. W., van der Straaten T., Hazes J. M., Ziegler-Heitbrock H. W., Nedospasov S. A., Breedveld F. C., Verweij C. L. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med. 1998 Nov;4(11):724–733. [PMC free article] [PubMed] [Google Scholar]
  17. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., Kollias G. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991 Dec;10(13):4025–4031. doi: 10.1002/j.1460-2075.1991.tb04978.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kroeger K. M., Carville K. S., Abraham L. J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997 Apr;34(5):391–399. doi: 10.1016/s0161-5890(97)00052-7. [DOI] [PubMed] [Google Scholar]
  19. Lacki J. K., Moser R., Korczowska I., Mackiewicz S., Muller W. TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int. 2000;19(4):137–140. doi: 10.1007/s002960050117. [DOI] [PubMed] [Google Scholar]
  20. Low A. S., Gonzalez-Gay M. A., Akil M., Amos R. S., Bax D. E., Cannings C., Hajeer A., Till S. H., Winfield J., Ollier W. E. TNF +489 polymorphism does not contribute to susceptibility to rheumatoid arthritis. Clin Exp Rheumatol. 2002 Nov-Dec;20(6):829–832. [PubMed] [Google Scholar]
  21. MacGregor A. J., Bamber S., Silman A. J. A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J Rheumatol. 1994 Aug;21(8):1420–1426. [PubMed] [Google Scholar]
  22. MacGregor A. J., Snieder H., Rigby A. S., Koskenvuo M., Kaprio J., Aho K., Silman A. J. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000 Jan;43(1):30–37. doi: 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  23. Mulcahy B., Waldron-Lynch F., McDermott M. F., Adams C., Amos C. I., Zhu D. K., Ward R. H., Clegg D. O., Shanahan F., Molloy M. G. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet. 1996 Sep;59(3):676–683. [PMC free article] [PubMed] [Google Scholar]
  24. Ota M., Katsuyama Y., Kimura A., Tsuchiya K., Kondo M., Naruse T., Mizuki N., Itoh K., Sasazuki T., Inoko H. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics. 2001 Feb 1;71(3):263–270. doi: 10.1006/geno.2000.6371. [DOI] [PubMed] [Google Scholar]
  25. Pociot F., Briant L., Jongeneel C. V., Mölvig J., Worsaae H., Abbal M., Thomsen M., Nerup J., Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 1993 Jan;23(1):224–231. doi: 10.1002/eji.1830230135. [DOI] [PubMed] [Google Scholar]
  26. Seki N., Kamizono S., Yamada A., Higuchi T., Matsumoto H., Niiya F., Kimura A., Tsuchiya K., Suzuki R., Date Y. Polymorphisms in the 5'-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens. 1999 Aug;54(2):194–197. doi: 10.1034/j.1399-0039.1999.540212.x. [DOI] [PubMed] [Google Scholar]
  27. Sham P. C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995 Jan;59(Pt 1):97–105. doi: 10.1111/j.1469-1809.1995.tb01608.x. [DOI] [PubMed] [Google Scholar]
  28. Sharp J. T. Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum. 1989 Feb;32(2):221–229. doi: 10.1002/anr.1780320218. [DOI] [PubMed] [Google Scholar]
  29. Stüber F., Petersen M., Bokelmann F., Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med. 1996 Mar;24(3):381–384. doi: 10.1097/00003246-199603000-00004. [DOI] [PubMed] [Google Scholar]
  30. Symmons D. P., Barrett E. M., Bankhead C. R., Scott D. G., Silman A. J. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol. 1994 Aug;33(8):735–739. doi: 10.1093/rheumatology/33.8.735. [DOI] [PubMed] [Google Scholar]
  31. Symmons D., Turner G., Webb R., Asten P., Barrett E., Lunt M., Scott D., Silman A. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 2002 Jul;41(7):793–800. doi: 10.1093/rheumatology/41.7.793. [DOI] [PubMed] [Google Scholar]
  32. Symmons Deborah P. M., Hazes Johanna M. W., Silman Alan J. Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis. J Rheumatol. 2003 May;30(5):902–904. [PubMed] [Google Scholar]
  33. Terry C. F., Loukaci V., Green F. R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000 Jun 16;275(24):18138–18144. doi: 10.1074/jbc.M000379200. [DOI] [PubMed] [Google Scholar]
  34. Uglialoro A. M., Turbay D., Pesavento P. A., Delgado J. C., McKenzie F. E., Gribben J. G., Hartl D., Yunis E. J., Goldfeld A. E. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens. 1998 Oct;52(4):359–367. doi: 10.1111/j.1399-0039.1998.tb03056.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Verweij C. L. Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis. Ann Rheum Dis. 1999 Nov;58 (Suppl 1):I20–I26. doi: 10.1136/ard.58.2008.i20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vinasco J., Beraún Y., Nieto A., Fraile A., Mataran L., Pareja E., Martín J. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens. 1997 Jan;49(1):74–78. doi: 10.1111/j.1399-0039.1997.tb02715.x. [DOI] [PubMed] [Google Scholar]
  37. Waldron-Lynch F., Adams C., Amos C., Zhu D. K., McDermott M. F., Shanahan F., Molloy M. G., O'Gara F. Tumour necrosis factor 5' promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun. 2001 Apr;2(2):82–87. doi: 10.1038/sj.gene.6363738. [DOI] [PubMed] [Google Scholar]
  38. Wiles N., Symmons D. P., Harrison B., Barrett E., Barrett J. H., Scott D. G., Silman A. J. Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum. 1999 Jul;42(7):1339–1346. doi: 10.1002/1529-0131(199907)42:7<1339::AID-ANR6>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  39. Wilson A. G., Symons J. A., McDowell T. L., McDevitt H. O., Duff G. W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195–3199. doi: 10.1073/pnas.94.7.3195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yen J. H., Chen C. J., Tsai W. C., Lin C. H., Ou T. T., Wu C. C., Liu H. W. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol. 2001 Aug;28(8):1788–1792. [PubMed] [Google Scholar]
  41. Zanelli E., Jones G., Pascual M., Eerligh P., van der Slik A. R., Zwinderman A. H., Verduyn W., Schreuder G. M., Roovers E., Breedveld F. C. The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. Hum Immunol. 2001 Jan;62(1):75–84. doi: 10.1016/s0198-8859(00)00227-5. [DOI] [PubMed] [Google Scholar]
  42. Zeggini Eleftheria, Thomson Wendy, Kwiatkowski Dominic, Richardson Anna, Ollier William, Donn Rachelle, British Paediatric Rheumatology Study Group Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis. Arthritis Rheum. 2002 Dec;46(12):3304–3311. doi: 10.1002/art.10698. [DOI] [PubMed] [Google Scholar]
  43. van der Heijde D. M. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol. 1995 Nov;34 (Suppl 2):74–78. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES